Ticagrelor Outperforms Clopidogrel for Unstable Angina with Better Inflammation Reduction | Research

The takeaway

Ticagrelor reduced angina frequency, duration, and inflammatory markers more effectively than clopidogrel in patients with unstable angina.

Multiple markers
Ticagrelor reduced CRP, IL-6, IL-18, MMP-9, MPO, ET-1, TNF-α more than clopidogrel

What the researchers found

Ticagrelor was superior to clopidogrel for angina symptoms and inflammatory marker reduction in unstable angina patients.

Why it matters

Choosing the right antiplatelet drug affects not just clotting but also the inflammatory processes driving coronary disease.

The numbers in context

Ticagrelor vs clopidogrel; lower BNP, CRP, IL-6, IL-18, MMP-9, TNF-alpha, and multiple other markers in the ticagrelor group (all P<0.05).

How the study worked

Comparative clinical study measuring angina symptoms and a comprehensive inflammatory biomarker panel.

Who was studied

Patients with coronary heart disease and unstable angina

What this study cannot tell us

Single study — specific methodology not detailed in abstract. Inflammatory markers are secondary to clinical outcomes.

How to read the evidence

Clinical comparative study — supportive evidence consistent with larger trial results favoring ticagrelor.

When this study was published

Published in 2025, adding inflammatory biomarker data to the ticagrelor vs. clopidogrel comparison.

The bigger picture

Ticagrelor's anti-inflammatory properties may contribute to its cardiovascular benefits beyond platelet inhibition alone.

Questions still open

Are ticagrelor's anti-inflammatory effects direct or secondary to better platelet inhibition?
Do these inflammatory benefits translate to fewer heart attacks long-term?

Common questions

Is ticagrelor better than clopidogrel?

For unstable angina, this study found ticagrelor reduced symptoms and inflammation more effectively, consistent with major trial evidence.

Why do anti-clotting drugs reduce inflammation?

Ticagrelor may have direct anti-inflammatory effects beyond platelet inhibition, reducing inflammatory molecules that drive heart disease.

Read the original research

Efficacy of ticagrelor and clopidogrel in treating unstable angina and their effects on serum inflammatory factors.

Pakistan journal of pharmaceutical sciences, 38(1), 77-82

View on PubMed ↗

Citation

Qin, Donghui; Ren, Yuanyuan; Zhang, Na; Yang, Xue; Chen, Zhuo; Zhao, Changliang. (2025). Efficacy of ticagrelor and clopidogrel in treating unstable angina and their effects on serum inflammatory factors.. Pakistan journal of pharmaceutical sciences, 38(1), 77-82.